PubRank

Tarik Tihan

Author PubWeight™ 142.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 2006 7.10
2 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009 5.13
3 Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med 2015 5.03
4 Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst 2005 4.63
5 Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008 3.98
6 The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003 3.89
7 Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008 2.92
8 Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol 2005 2.58
9 Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 2008 2.40
10 Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Neurosurg Focus 2005 2.22
11 Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery 2015 1.99
12 Pleiotropic role for MYCN in medulloblastoma. Genes Dev 2010 1.84
13 Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011 1.77
14 A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 2012 1.73
15 Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg 2010 1.72
16 Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg 2011 1.67
17 Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 2007 1.66
18 Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev 2012 1.64
19 Comprehensive management of symptomatic and aggressive vertebral hemangiomas. Neurosurg Clin N Am 2008 1.57
20 Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev 2008 1.56
21 Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 2008 1.56
22 Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg 2010 1.55
23 Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol 2007 1.53
24 Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery 2004 1.47
25 SNPLogic: an interactive single nucleotide polymorphism selection, annotation, and prioritization system. Nucleic Acids Res 2008 1.42
26 Current treatment strategies and outcomes in the management of symptomatic vertebral hemangiomas. Neurosurgery 2006 1.40
27 Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 2011 1.35
28 Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005 1.33
29 Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am J Physiol Endocrinol Metab 2002 1.32
30 DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro Oncol 2011 1.29
31 Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg 2006 1.28
32 Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 2005 1.27
33 The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol 2015 1.27
34 CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci 2010 1.26
35 Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2008 1.25
36 Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 2009 1.25
37 Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol 2010 1.23
38 Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol 2013 1.20
39 Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res 2011 1.20
40 Biomarkers to predict response to epidermal growth factor receptor inhibitors. Cell Cycle 2005 1.19
41 Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg 2007 1.14
42 Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol 2008 1.13
43 Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol 2013 1.11
44 Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction. Neoplasia 2008 1.11
45 Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res 2007 1.11
46 Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol 2012 1.11
47 MR imaging characteristics of pilomyxoid astrocytomas. AJNR Am J Neuroradiol 2003 1.10
48 A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol 2013 1.09
49 Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke 2012 1.08
50 Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. J Neuropathol Exp Neurol 2013 1.06
51 Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol 2004 1.06
52 The pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity. J Neurooncol 2006 1.05
53 Pilomyxoid astrocytoma: a review. MedGenMed 2004 1.02
54 Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 2010 1.02
55 Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 2005 1.00
56 Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization. Arch Pathol Lab Med 2010 0.98
57 Impact of telemedicine on pediatric neuro-oncology in a developing country: the Jordanian-Canadian experience. Pediatr Blood Cancer 2007 0.97
58 Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation. Transl Stroke Res 2012 0.97
59 Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol 2014 0.97
60 Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis. Neuro Oncol 2012 0.96
61 Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol 2009 0.95
62 Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 2010 0.95
63 High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 2009 0.93
64 Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci 2011 0.92
65 The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol 2012 0.92
66 HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery. Mol Ther 2008 0.91
67 Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells. Cancer Chemother Pharmacol 2004 0.88
68 Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J Neurosurg Pediatr 2010 0.88
69 Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol 2003 0.88
70 Trends in childhood brain tumor incidence, 1973-2009. J Neurooncol 2013 0.88
71 Myxopapillary ependymoma: cytomorphologic characteristics and differential diagnosis. Diagn Cytopathol 2002 0.87
72 Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization. Neurosurg Focus 2009 0.87
73 Secondary gliosarcoma: a review of clinical features and pathological diagnosis. J Neurosurg 2010 0.87
74 Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants. Mod Pathol 2012 0.86
75 Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Mol Cancer Res 2012 0.86
76 Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes. J Clin Neurosci 2010 0.85
77 Intracranial dermoid cyst mimicking hemorrhage. Case report and review of the literature. J Neurosurg 2006 0.85
78 Predictors of seizure freedom after surgery for malformations of cortical development. Ann Neurol 2011 0.84
79 Pilomyxoid astrocytoma of the spinal cord: report of three cases. Neurosurgery 2005 0.84
80 Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia. J Neurooncol 2008 0.84
81 Transmantle sign in focal cortical dysplasia: a unique radiological entity with excellent prognosis for seizure control. J Neurosurg 2012 0.84
82 Basaloid follicular hamartoma with trichoblastomatous proliferations. J Cutan Med Surg 2003 0.84
83 Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985-2005. Neurosurgery 2010 0.84
84 Magnetic resonance imaging characteristics of pilomyxoid astrocytoma. Neurol Res 2008 0.84
85 Optic pathway gliomas: a review. CNS Oncol 2013 0.83
86 Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 2003 0.83
87 Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care 2010 0.83
88 Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy. Proc Natl Acad Sci U S A 2013 0.82
89 Desmoplastic noninfantile ganglioglioma: report of a case. Pediatr Dev Pathol 2006 0.82
90 Genetic aberrations in gliomatosis cerebri. Neurosurgery 2007 0.82
91 Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. J Clin Neurosci 2010 0.81
92 Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol 2009 0.80
93 Solitary fibrous tumor arising from Cranial Nerve VI in the prepontine cistern: case report and review of a tumor subpopulation mimicking schwannoma. Neurosurgery 2006 0.80
94 The molecular pathology of central neurocytomas. J Clin Neurosci 2010 0.80
95 SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res 2012 0.79
96 The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients. Neurosurgery 2011 0.79
97 Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system. Mod Pathol 2013 0.79
98 Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma: a plea for a revision of the current WHO classification. CNS Oncol 2013 0.79
99 Retro-convection enhanced delivery to increase blood to brain transfer of macromolecules. Brain Res 2006 0.79
100 Recurrent glioependymal cyst of the posterior fossa: an unusual entity containing mixed glial elements. Case report. J Neurooncol 2004 0.78
101 The morphologic and molecular characteristics of pilocytic astrocytomas and the role of MAPK pathway: what does not kill you makes you stronger. Adv Anat Pathol 2014 0.78
102 A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia. Nat Clin Pract Neurol 2008 0.78
103 The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms. J Neurooncol 2007 0.78
104 Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 2016 0.78
105 Temporal fossa hemangiopericytoma: a case series. Otol Neurotol 2009 0.77
106 Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients. Neurosurgery 2013 0.77
107 Accreditation council for graduate medical education (ACGME) competencies in neuropathology training. J Neuropathol Exp Neurol 2005 0.77
108 Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells. Nucleosides Nucleotides Nucleic Acids 2004 0.76
109 Clinical management of pituitary carcinomas. Neurosurg Clin N Am 2012 0.76
110 Morphological analysis of CDC2 and glycogen synthase kinase 3β phosphorylation as markers of g2 → m transition in glioma. Patholog Res Int 2011 0.75
111 Correction: Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1. PLoS One 2017 0.75
112 Morphometric characterization of brain arteriovenous malformations for clinical and radiological studies to identify silent intralesional microhemorrhages. Clin Neuropathol 2016 0.75
113 Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases. Clin Neuropathol 2016 0.75
114 A subclavian artery aneurysm in a patient with HIV infection: a case report. J Vasc Surg 2002 0.75
115 The role of pathology experts in defining practice gaps in continuing pathology education: what do we need to know and how can we find them? Adv Anat Pathol 2012 0.75
116 Spectroscopic imaging of serum proteins using quantum cascade lasers. J Biomed Opt 2013 0.75
117 Emergence of a high-grade sarcoma in a recurrent meningioma: malignant progression or collision tumor? Arch Pathol Lab Med 2011 0.75
118 Occipital ganglioglioma in an older adult. J Clin Neurosci 2010 0.75
119 850 Glioma Patients Segregate into Two Distinct Immunosuppresssive Phenotypes Based on PTEN Status: Implications for Immunotherapy. Neurosurgery 2005 0.75
120 Subacute cystic expansion of intracranial juvenile psammomatoid ossifying fibroma. J Neurosurg Pediatr 2013 0.75
121 Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair. Arch Pathol Lab Med 2008 0.75
122 Atypical cases of scleroderma en coup de sabre. J Child Neurol 2014 0.75
123 Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population: a retrospective series of hemimegalencephaly and Rasmussen's encephalitis. J Neurosurg Pediatr 2014 0.75
124 Solitary central nervous system metastasis from acinic cell carcinoma of the parotid gland. J Otolaryngol 2002 0.75
125 Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol 2015 0.75
126 Surgical resection and adjuvant radiotherapy for a large pineal hemangiopericytoma. J Clin Neurosci 2010 0.75
127 Epidemiology and pathology of intraventricular tumors. Neurosurg Clin N Am 2003 0.75
128 Duodenal reflux produces hyperproliferative epithelial esophagitis--a possible precursor to esophageal adenocarcinoma in the rat. J Gastrointest Surg 2003 0.75
129 Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma. J Neurooncol 2011 0.75
130 Pure germinomas of the central nervous system: treatment strategies and outcomes. J Neurooncol 2014 0.75
131 Solitary Fibrous Tumor/Hemangiopericytoma Dichotomy Revisited: A Restless Family of Neoplasms in the CNS. Adv Anat Pathol 2016 0.75
132 Post-radiation reactive changes in a single vertebral body mimicking metastatic pineoblastoma. J Neurosurg Pediatr 2009 0.75
133 Internet and World Wide Web-based tools for neuropathology practice and education. Brain Pathol 2009 0.75
134 Management of a sporadic malignant subfrontal peripheral nerve sheath tumor. J Neurooncol 2006 0.75
135 Falcine and parasagittal chondrosarcomas. J Clin Neurosci 2013 0.75
136 Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution. Clin Neuropathol 2014 0.75